PMV Pharmaceuticals Lands $30,000,000 Series A Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=10bbd273-801a-48d3-a796-ca6f21bb8bfd
Date
12/3/2014
Company Name
PMV Pharmaceuticals
Mailing Address
497 Seaport Court Redwood City, CA 94063 USA
Company Description
PMV Pharmaceuticals is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV combines unique biological understanding with pharmaceutical development focus.
Website
http://www.pmvpharma.com
Transaction Type
Venture Equity
Transaction Amount
$30,000,000
Transaction Round
Series A
Proceeds Purposes
The proceeds of this financing will support the advancement of the Company’s rapidly emerging pipeline of p53 focused therapeutics.
M&A Terms
Venture Investor
Venture Investor
Venture Investor